Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 

With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Scientists from countries with fewer resources are pushing collaborators from higher-income countries to shed biases and behaviors that perpetuate social stratification in the research community.

As we stand on the brink of a new scientific age, how researchers should best communicate their findings and innovations is hotly debated in the publishing trenches.

An influential paper on amyloid protein and Alzheimer’s disease potentially fabricated data. Why did it take 16 years to flag?

Economists explore the wheelings and dealings of universities and publishers during largely secret negotiations regarding access to scientific journals.

14-day-old embryos, prioritizing biodiversity, and more

Biologist David Gruber studies radiant creatures and their fluorescent proteins.

From disastrous scientific setbacks to the upending of scientific dogma and the end of a 40-year search for a protein

The epigenetic modification of brain cells undergoes great shifts over the course of mouse and human development.